OTRIVINE 1 MG/ML FL 10 ML

Description

Indications

• Non-allergic rhinitis (head colds)
• seasonal and non-seasonal allergic rhinitis
• sinusitis (helps eliminate secretions)
• otitis media (as an adjuvant to nasopharyngeal decongestion)

Adults and children over 6 years of age

1 spray in each nostril, 1 to 2 times a day
Minimum interval between 2 applications: 4 to 6 hours

Otrivine,1 mg/ml, solution:Xylometazoline hydrochloride 1 mg per ml (corresponding to 0.87 mg/ml xylometazoline).
(25 µg xylometazoline hydrochloride per drop, 40 drops per ml, 140 µg xylometazoline hydrochloride per spray).

Notable excipients: This medicine contains benzalkonium chloride as a preservative. This substance may be irritant and cause skin reactions.

Short-term symptomatic treatment (maximum 3 to 5 days) of nasal congestion in certain conditions such as:- non-allergic rhinitis (common cold)
– seasonal and non-seasonal allergic rhinitis
– sinusitis (facilitates the elimination of secretions)
– otitis media (as an aid in decongesting the nasopharynx)

The excipients sorbitol and methylhydroxypropylcellulose present in Otrivine may help prevent the nasal mucosa from drying out.

As with all nasal preparations containing a vasoconstrictor, Otrivine cannot be used as a maintenance treatment.

Otrivine 1 mg/ml is intended for adults and children aged 12 and over.

Otrivine 1 mg/ml solution for nasal instillation for adults and children aged 12 and over:
– 2 to 4 drops in each nostril,
– 3 times a day
– between 2 administrations
– an interval of 8 to 10 hours should be observed
– no more than 3 administrations per nostril per day.

Use of the solution for nasal instillation :
1. Blow your nose.
2. Tilt your head back as far as is comfortable or, if you are lying in bed, let your head hang over the edge of the bed.
3. Administer the drops into each nostril and keep your head tilted back for a short time, so that the drops can distribute themselves in the nasal cavity.
4. Clean the dropper and leave it to dry before returning it to the bottle.

To prevent the infection spreading, the bottle may only be used by 1 person.

Hypersensitivity to the active substance or to any of the excipients mentioned in section 6.1 or to other sympathicomimetic amines – Angle-closure glaucoma.
Patients treated with MAOIs, due to the risk of severe hypertensive crisis.
Atrophic rhinitis.
Otrivine cannot be used after trans-sphenoidal hypophysectomy or after nasal or buccal procedures in which the dura mater has been exposed.

It should be noted that both formulations of Otrivine 1 mg/ml are intended exclusively for adults and children aged 12 and over.

Otrivine is a nasal decongestant based on xylometazoline (1mg/ml).
In the event of a blocked nose due to a cold or sinusitis, Otrivine 1mg/ml:
– Clears the nose in a few minutes.
– Relieves for up to 10 hours.
– Helps prevent irritation of the nasal mucosa.
– For use from the age of 12.
– Xylometazoline has no effect on the function of the ciliary epithelium.

The presence of sorbitol and methylhydroxypropylcellulose as excipients in Otrivine may help to prevent the nasal mucosa from drying out.